NeuroDiag: Software for Automated Diagnosis of Parkinson's Disease Using Handwriting.

OBJECTIVE: A change in handwriting is an early sign of Parkinson's disease (PD). However, significant inter-person differences in handwriting make it difficult to identify pathological handwriting, especially in the early stages. This paper reports the testing of NeuroDiag, a software-based medical device, for the automated detection of PD using handwriting patterns. NeuroDiag is designed to direct the user to perform six drawing and writing tasks, and the recordings are then uploaded onto a server for analysis. Kinematic information and pen pressure of handwriting are extracted and used as baseline parameters. NeuroDiag was trained based on 26 PD patients in the early stage of the disease and 26 matching controls. METHODS: Twenty-three people with PD (PPD) in their early stage of the disease, 25 age-matched healthy controls (AMC), and 7 young healthy controls were recruited for this study. Under the supervision of a consultant neurologist or their nurse, the participants used NeuroDiag. The reports were generated in real-time and tabulated by an independent observer. RESULTS: The participants were able to use NeuroDiag without assistance. The handwriting data was successfully uploaded to the server where the report was automatically generated in real-time. There were significant differences in the writing speed between PPD and AMC (P<0.001). NeuroDiag showed 86.96% sensitivity and 76.92% specificity in differentiating PPD from those without PD. CONCLUSION: In this work, we tested the reliability of NeuroDiag in differentiating between PPD and AMC for real-time applications. The results show that NeuroDiag has the potential to be used to assist neurologists and for telehealth applications. Clinical and Translational Impact Statement - This pre-clinical study shows the feasibility of developing a community-wide screening program for Parkinson's disease using automated handwriting analysis software, NeuroDiag.

On the inter-dataset generalization of machine learning approaches to Parkinson's disease detection from voice.

BACKGROUND AND OBJECTIVE: Parkinson's disease is the second-most-common neurodegenerative disorder that affects motor skills, cognitive processes, mood, and everyday tasks such as speaking and walking. The voices of people with Parkinson's disease may become weak, breathy, or hoarse and may sound emotionless, with slurred words and mumbling. Algorithms for computerized voice analysis have been proposed and have shown highly accurate results. However, these algorithms were developed on single, limited datasets, with participants possessing similar demographics. Such models are prone to overfitting and are unsuitable for generalization, which is essential in real-world applications. METHODS: We evaluated the computerized Parkinson's disease diagnosis performance of various machine learning models and showed that these models degraded rapidly when used on different datasets. We evaluated two mainstream state-of-the-art approaches, one based on deep convolutional neural networks and another based on voice feature extraction followed by a shallow classifier (i.e., extreme gradient boosting (XGBoost)). RESULTS: An investigation with four datasets (CzechPD, PC-GITA, ITA, and RMIT-PD) proved that even if the algorithms yielded excellent performance on a single dataset, the results obtained on new data or even a mix of datasets were very unsatisfactory. CONCLUSIONS: More work needs to be done to make computerized voice analysis methods for Parkinson's disease diagnosis suitable for real-world applications.

Computerized analysis of speech and voice for Parkinson's disease: A systematic review.

BACKGROUND AND OBJECTIVE: Speech impairment is an early symptom of Parkinson's disease (PD). This study has summarized the literature related to speech and voice in detecting PD and assessing its severity. METHODS: A systematic review of the literature from 2010 to 2021 to investigate analysis methods and signal features. The keywords "Automatic analysis" in conjunction with "PD speech" or "PD voice" were used, and the PubMed and ScienceDirect databases were searched. A total of 838 papers were found on the first run, of which 189 were selected. One hundred and forty-seven were found to be suitable for the review. The different datasets, recording protocols, signal analysis methods and features that were reported are listed. Values of the features that separate PD patients from healthy controls were tabulated. Finally, the barriers that limit the wide use of computerized speech analysis are discussed. RESULTS: Speech and voice may be valuable markers for PD. However, large differences between the datasets make it difficult to compare different studies. In addition, speech analytic methods that are not informed by physiological understanding may alienate clinicians. CONCLUSIONS: The potential usefulness of speech and voice for the detection and assessment of PD is confirmed by evidence from the classification and correlation results.

Computerised prediction of healing for venous leg ulcers.

Early prediction of delayed healing for venous leg ulcers could improve management outcomes by enabling earlier initiation of adjuvant therapies. In this paper, we propose a framework for computerised prediction of healing for venous leg ulcers assessed in home settings using thermal images of the 0 week. Wound data of 56 older participants over 12 weeks were used for the study. Thermal images of the wounds were collected in their homes and labelled as healed or unhealed at the 12th week follow up. Textural information of the thermal images at week 0 was extracted. Thermal images of unhealed wounds had a higher variation of grey tones distribution. We demonstrated that the first three principal components of the textural features from one timepoint can be used as an input to a Bayesian neural network to discriminate between healed and unhealed wounds. Using the optimal Bayesian neural network, the classification results showed 78.57% sensitivity and 60.00% specificity. This non-contact method, incorporating machine learning, can provide a computerised prediction of this delay in the first assessment (week 0) in participants' homes compared to the current method that is able to do this in 3rd week and requires contact digital planimetry.